Page last updated: 2024-11-02

oxidopamine and ANS (Autonomic Nervous System) Diseases

oxidopamine has been researched along with ANS (Autonomic Nervous System) Diseases in 5 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research Excerpts

ExcerptRelevanceReference
" In this study, we investigated the effects of aging-associated formaldehyde (FA) on the inactivation of NE in vitro and in vivo, and on memory behaviors in rodents."7.81Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline. ( Jia, J; Jiang, C; Lv, J; Mei, Y; Tong, Z; Wan, Y; Wang, X; Yang, X, 2015)
" In this study, we investigated the effects of aging-associated formaldehyde (FA) on the inactivation of NE in vitro and in vivo, and on memory behaviors in rodents."3.81Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline. ( Jia, J; Jiang, C; Lv, J; Mei, Y; Tong, Z; Wan, Y; Wang, X; Yang, X, 2015)
" Moreover, 18 at a dosage of 10 mg/kg was found to be significantly neuroprotective in a mouse peripheral sympathetic nerve injury model induced by 8 mg/kg 6-hydroxydopamine."1.33FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates. ( Hu, Y; Huang, W; Li, S; Liu, H; Wang, L; Xiao, J; Zhao, L; Zhong, W, 2006)
"The tachycardia was abolished by treatment with the beta-antagonist propranolol, demonstrating that it was mediated by catecholamines acting on cardiac beta-receptors."1.31Animal model of neuropathic tachycardia syndrome. ( Appalsamy, M; Carson, RP; Davis, TL; Diedrich, A; Robertson, D, 2001)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mei, Y1
Jiang, C1
Wan, Y1
Lv, J1
Jia, J1
Wang, X1
Yang, X1
Tong, Z1
Zhao, L1
Huang, W1
Liu, H1
Wang, L1
Zhong, W1
Xiao, J1
Hu, Y1
Li, S1
Chelmicka-Schorr, E1
Arnason, BG1
Obayashi, K1
Ando, Y1
Terazaki, H1
Yamashita, T1
Nakamura, M1
Suga, M1
Uchino, M1
Ando, M1
Carson, RP1
Appalsamy, M1
Diedrich, A1
Davis, TL1
Robertson, D1

Other Studies

5 other studies available for oxidopamine and ANS (Autonomic Nervous System) Diseases

ArticleYear
Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline.
    Aging cell, 2015, Volume: 14, Issue:4

    Topics: Aging; Animals; Autonomic Nervous System Diseases; Dopamine beta-Hydroxylase; Formaldehyde; Hippocam

2015
FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.
    Journal of medicinal chemistry, 2006, Jul-13, Volume: 49, Issue:14

    Topics: Animals; Autonomic Nervous System Diseases; Chick Embryo; Databases, Factual; Drug Design; Ganglia,

2006
Nervous system-immune system interactions and their role in multiple sclerosis.
    Annals of neurology, 1994, Volume: 36 Suppl

    Topics: Animals; Animals, Newborn; Autoimmunity; Autonomic Nervous System Diseases; Comorbidity; Humans; Imm

1994
Mechanism of anemia associated with autonomic dysfunction in rats.
    Autonomic neuroscience : basic & clinical, 2000, Aug-14, Volume: 82, Issue:3

    Topics: Adrenergic beta-Antagonists; Anemia; Animals; Autonomic Nervous System Diseases; Blood Cell Count; B

2000
Animal model of neuropathic tachycardia syndrome.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:6

    Topics: Adrenergic Agents; Animals; Autonomic Nervous System Diseases; Blood Pressure; Disease Models, Anima

2001